|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07D 498/22 | |
| A61K 31/437 | |||
| A61P 31/04 |
| (11) | Number of the document | 2536734 |
| (13) | Kind of document | T |
| (96) | European patent application number | 11745134.4 |
| Date of filing the European patent application | 2011-02-16 | |
| (97) | Date of publication of the European application | 2012-12-26 |
| (45) | Date of publication and mention of the grant of the patent | 2016-08-31 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2011/024981 |
| Date | 2011-02-16 |
| (87) | Number | WO 2011/103120 |
| Date | 2011-08-25 |
| (30) | Number | Date | Country code |
| 708836 | 2010-02-19 | US |
| (72) |
GUSHURST, Karen, S., US
YANG, Donglai, US
VLAHOVA, Petinka, US
STULTS, Jeffrey, S., US
|
| (73) |
Salix Pharmaceuticals, Ltd.,
400 Somerset Corporate Blvd., Bridgewater, NJ 08807,
US
|
| (54) | FORMS OF RIFAXIMIN AND USES THEREOF |
| FORMS OF RIFAXIMIN AND USES THEREOF |